These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 10037168

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The use of conventional antipsychotic medications for patients with schizophrenia in a medicaid population: therapeutic and cost outcomes over 2 years.
    McCombs JS, Luo M, Johnstone BM, Shi L.
    Value Health; 2000; 3(3):222-31. PubMed ID: 16464186
    [Abstract] [Full Text] [Related]

  • 4. The cost of schizophrenia.
    Wasylenki DA.
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S65-9. PubMed ID: 7874667
    [Abstract] [Full Text] [Related]

  • 5. Perspective and the measurement of costs and benefits for cost-effectiveness analysis in schizophrenia.
    Meltzer D.
    J Clin Psychiatry; 1999 Nov; 60 Suppl 3():32-5; discussion 36-7. PubMed ID: 10073375
    [Abstract] [Full Text] [Related]

  • 6. Looking beyond the formulary budget in cost-benefit analysis.
    Cohen LJ.
    Am J Manag Care; 1997 Feb; 3 Suppl():S11-7. PubMed ID: 10180337
    [Abstract] [Full Text] [Related]

  • 7. Methods of cost-effectiveness analysis in the evaluation of new antipsychotics: implications for schizophrenia treatment.
    Neumann PJ.
    J Clin Psychiatry; 1999 Feb; 60 Suppl 3():9-14; discussion 15. PubMed ID: 10073371
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T, Weinbrenner S, Busse R, Juckel G, Gericke CA.
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [Abstract] [Full Text] [Related]

  • 9. Methods of pharmacoeconomic evaluation of psychopharmacologic therapies for patients with schizophrenia.
    Revicki DA.
    J Psychiatry Neurosci; 1997 Jul; 22(4):256-66. PubMed ID: 9262048
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacoeconomic factors related to the treatment of schizophrenia. Concluding discussion.
    J Clin Psychiatry; 1999 Jul; 60 Suppl 3():59-60. PubMed ID: 10073380
    [No Abstract] [Full Text] [Related]

  • 13. The functionality and economic costs of outpatients with schizophrenia in Taiwan.
    Lee IH, Chen PS, Yang YK, Liao YC, Lee YD, Yeh TL, Yeh LL, Cheng SH, Chu CL.
    Psychiatry Res; 2008 Apr 15; 158(3):306-15. PubMed ID: 18243334
    [Abstract] [Full Text] [Related]

  • 14. Outpatient antipsychotic treatment and inpatient costs of schizophrenia.
    Marcus SC, Olfson M.
    Schizophr Bull; 2008 Jan 15; 34(1):173-80. PubMed ID: 17578893
    [Abstract] [Full Text] [Related]

  • 15. Atypical antipsychotics in the managed care era.
    Loebel AD, Botts SR, Feldman BI.
    Am J Manag Care; 1998 Jan 15; 4 Suppl():S37-50; quiz S51-2. PubMed ID: 10181074
    [Abstract] [Full Text] [Related]

  • 16. Improving mental health treatments through comparative effectiveness research.
    Wang PS, Ulbricht CM, Schoenbaum M.
    Health Aff (Millwood); 2009 Jan 15; 28(3):783-91. PubMed ID: 19414887
    [Abstract] [Full Text] [Related]

  • 17. The treatment of psychosis: resetting the drug cost 'thermostat'.
    Reid WH.
    J Clin Psychiatry; 1994 Sep 15; 55 Suppl B():166-8. PubMed ID: 7961565
    [Abstract] [Full Text] [Related]

  • 18. Annual health outcomes and treatment costs for schizophrenia populations.
    Mauskopf JA, David K, Grainger DL, Gibson PJ.
    J Clin Psychiatry; 1999 Sep 15; 60 Suppl 19():14-9; discussion 20-2. PubMed ID: 10507276
    [Abstract] [Full Text] [Related]

  • 19. [Expensive but nevertheless cost effect? Pharmacoeconomics of atypical neuroleptics].
    Laux G, Günther W.
    Pharm Unserer Zeit; 2002 Sep 15; 31(6):572-6. PubMed ID: 12481515
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.